Harmony Biosciences Inc. (HRMY) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Harmony Biosciences Inc.

    NASDAQ: HRMY · Real-Time Price · USD
    27.20
    0.16 (0.59%)
    At close: Sep 26, 2025, 1:37 PM

    Harmony Biosciences Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 714.73M 582.02M 437.86M 305.44M
    Cost of Revenue
    		 156.81M 121.24M 83.48M 55.52M
    Gross Profit
    		 557.92M 460.79M 354.37M 249.92M
    Operating Income
    		 190.83M 192.03M 120.19M 68.7M
    Interest Income
    		 18.54M 14.73M 3.13M 223K
    Pretax Income
    		 191.8M 173.4M 104.69M 37.43M
    Net Income
    		 145.49M 128.85M 181.47M 34.6M
    Selling & General & Admin
    		 221.27M 192.69M 163.3M 132.03M
    Research & Development
    		 145.82M 76.06M 70.89M 30.37M
    Other Expenses
    		 n/a n/a 169K 16K
    Operating Expenses
    		 367.09M 268.76M 234.19M 162.39M
    Interest Expense
    		 17.5M 23.76M 18.8M 23.97M
    Selling & Marketing Expenses
    		 110.92M 97.4M 79.28M 68.12M
    Cost & Expenses
    		 523.91M 389.99M 317.67M 217.91M
    Income Tax Expense
    		 46.31M 44.54M -76.78M 2.83M
    Shares Outstanding (Basic)
    		 56.88M 59.47M 59.17M 57.53M
    Shares Outstanding (Diluted)
    		 57.87M 60.37M 61.1M 59.21M
    EPS (Basic)
    		 2.56 2.17 3.07 0.60
    EPS (Diluted)
    		 2.51 2.13 2.97 0.58
    EBITDA
    		 233.41M 221.51M 143.57M 106.37M
    EBIT
    		 209.3M 197.15M 120.19M 61.62M
    Depreciation & Amortization
    		 24.11M 24.36M 23.39M 18.84M

    Add to Watchlist